Results 301 to 310 of about 854,189 (388)

Large Ovarian Fibroma With Torsion in a 17-Year-Old Patient: A Report of a Rare Case of Acute Surgical Abdomen. [PDF]

open access: yesCureus
Xydias EM   +7 more
europepmc   +1 more source

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

open access: yesInternational Journal of Cancer, EarlyView.
What's New? CATCH is a prospective precision oncology registry trial that harnesses whole‐genome/exome‐ and RNA‐sequencing to enable actionable biomarker detection in metastatic breast cancer patients of any subtype. The data of the first 412 consecutive patients with completed follow‐up in this real‐world, single‐center patient cohort provide robust ...
Mario Hlevnjak   +31 more
wiley   +1 more source

Fast enrichment and detection of circulating tumor cells from large volumes of whole blood of breast cancer patients utilizing a functionalized bioaffinity CTC filtration membrane

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Circulating tumor cells (CTCs) are promising prognostic biomarkers for cancer. CTCs are sometimes very sparse; however, they present technical challenges for their enrichment from whole blood. Here, the authors tested the CTC enrichment capacity of a new nickel‐based filtration membrane and compared its efficacy to that of an FDA‐approved ...
Leonie F. Ott   +26 more
wiley   +1 more source

Creation and Implementation of an Electronic Sexual Assault Record at the Geneva University Hospital.

open access: yesJMIR Med Inform
Cottler-Casanova S   +4 more
europepmc   +1 more source

Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Most patients with ovarian cancer (OC) relapse after first‐line chemotherapy, and prognosis with second‐line treatment depends largely on the platinum‐free interval. However, reliable biomarkers to predict response to second‐line therapy remain lacking.
Muhammad Habiburrahman   +7 more
wiley   +1 more source

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Mònica Ortega Llobet   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy